HealthQuill FDA
AbbVie Inc and Danish drugmaker, Genmab, announced they have got FDA’s approval for a therapy to treat blood cancer in adults who have undergone at least two prior treatments.
Drugs Health Medical Pharma

AbbVie, Genmab get FDA approval for blood cancer therapy

HQ Team May 20, 2023: AbbVie Inc and Danish drugmaker, Genmab, announced they have got FDA’s approval for a therapy to treat blood.

Read More
Astellas Pharma, a Japanese drugmaker, announced that the FDA has approved its oral drug Veozah for the treatment of hot flushes in menopausal women.
Drugs Health Pharma

Astellas drug to treat menopausal hot flashes gets FDA’s green light

HQ Team May 14, 2023: Astellas Pharma, a Japanese drugmaker, announced that the FDA has approved its oral drug Veozah for the treatment.

Read More
The FDA has warned consumers against the use of fast-act rheum and UA-Block capsules used to treat inflammation and joint pains as it contains substances that raise blood sugar, heart attacks, and stroke.
Drugs Health Medical Pharma

FDA warns against use of Fast-act and UA-Block capsules to treat rheumatism

HQ Team May 11, 2023: The FDA has warned consumers against using fast-act rheum and UA-Block capsules to treat inflammation and joint pains.

Read More
The USFDA has warned healthcare providers and consumers from using SD Biosensor Inc. pilot COVID-19 at-home tests due to bacterial contamination.
Drugs Health Medical Pharma

FDA issues warning on SD Biosensor’s at-home COVID-19 test

HQ Team May 5, 2023: The USFDA has warned healthcare providers and consumers from using SD Biosensor Inc. pilot COVID-19 at-home tests due.

Read More
The FDA has granted accelerated approval for an intravenous drug to treat Alzheimer's Disease, according to a statement.
Drugs Health Medical Pharma

GSK gets FDA nod for adult respiratory syncytial virus (RSV) vaccine

GSK races ahead of rivals Pfizer and Moderna in getting FDA approval for RSV vaccine.

Read More
Del Maguey Co., majority-owned by Pernod Ricard, will voluntarily recall certain ceramic ware artisan cups used to drink an alcoholic beverage, mezcal, in the US due to excess levels of leachable lead.
Drugs Health Medical Pharma

Del Maguey pulls out mezcal cups from US on leachable lead risk

HQ Team May 2, 2023: Del Maguey Co., majority-owned by Pernod Ricard, will voluntarily recall certain ceramic ware artisan cups used to drink.

Read More
TruVision Health, a US-based healthcare company, will recall its dozen unapproved dietary products after an FDA inspection found them to be adulterated.
Drugs Health Medical Pharma

TruVision to recall adulterated dietary products after FDA inspection

HQ Team May 2, 2023: TruVision Health, a US-based healthcare company, will recall its dozen unapproved dietary products after an FDA inspection found.

Read More
The US Food and Drug Administration has cleared Biogen Inc’s drug, branded as Qalsody, to treat amyotrophic lateral sclerosis (ALS), an aggressive and rare form of the disease in adults.
Drugs Health Medical Pharma

Biogen’s sclerosis drug gets FDA’s fast approval clearance

HQ Team April 26, 2023: The US Food and Drug Administration has cleared Biogen Inc’s drug, branded as Qalsody, to treat amyotrophic lateral.

Read More
SAB Biotherapeutics got a fast-track designation from the USFDA for its investigational drug to treat influenza in high-risk and immunocompromised patients.
Drugs Medical Pharma

SAB gets FDA fast track nod for experimental drug to treat influenza

HQ Team April 14, 2023: SAB Biotherapeutics got a fast-track designation from the USFDA for its investigational drug to treat influenza in high-risk.

Read More
New safety warnings will be required on prescription labels for opioid pain relievers to prevent addiction and overdose, the FDA stated.
Drugs Health Medical Pharma

USFDA updates safety warnings for opioid treatment drugs 

HQ Team April 14, 2023: New safety warnings will be required on prescription labels for opioid pain relievers to prevent addiction and overdose,.

Read More